Invention Grant
US09409922B2 Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
有权
咪唑并吡啶大环化合物作为人体免疫缺陷病毒复制的抑制剂
- Patent Title: Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
- Patent Title (中): 咪唑并吡啶大环化合物作为人体免疫缺陷病毒复制的抑制剂
-
Application No.: US14619213Application Date: 2015-02-11
-
Publication No.: US09409922B2Publication Date: 2016-08-09
- Inventor: Kevin Peese , Zhongyu Wang , John F. Kadow , Prasanna Sivaprakasam , B. Narasimhulu Naidu
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D498/22
Abstract:
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
Public/Granted literature
- US20150232480A1 Imidazopyridine Macrocycles as Inhibitors of Human Immunodeficiency Virus Replication Public/Granted day:2015-08-20
Information query
